Researchers Develop Technology to Determine Animal Male Sex Selection
News Release
FOR IMMEDIATE RELEASE
December 21, 2015
CONTACT: Suzanna Cisneros, suzanna.cisneros@ttuhsc.edu
(806) 743-7605
Researchers Develop Technology to Determine Animal Male Sex Selection
Texas Tech University Health Sciences Center (TTUHSC) researchers have developed a low cost technology related to sex select semen that can be used with artificial insemination in animals.
Samuel Prien, Ph.D., and Lindsay Penrose, Ph.D., both with the TTUHSC Department of Ob/Gyn, completed their research, “A Prepatory Technique for Semen Selection.” By developing a method to chemically attract the sperm to what is a favorable environment, the research found conception of a male could be as high as 72 percent.
“We provide sperm with numerous environmental choices at the same time,” Prien said. “By providing a chemical trail for the cell to follow, it can biochemically select its preferred environment. The technology uses simple chemical properties to affect sperm movement allowing separation of X and Y type sperm for insemination in animals.”
Cytometric sorting, the current available, yet expensive, technology can be used to separate sperm based on sex chromosome content. Penrose said by using chemotaxis, the researchers targeted the cells by allowing the sperm to follow a chemical trail. During chemotaxis, cells move in response to chemical signals.
“The course of our research allowed us to select for males first,” Penrose said. “But
with modification, selection for females is possible as well. We found that the cell
would pick the preferred chemical pathway and follow it. Over the years, a tremendous
amount of resources have been spent on searching for techniques that are practical
in a wide variety of settings. Flow cytometry is one, but, it is extremely costly,
and there are concerns over the safety of the procedure.”
The technology has received a patent from the U.S. Patent and Trademark Office for
“Method and Apparatus for Gender Selection.” The patent rights have been licensed
to Reproductive Solutions Inc. SureBreed™ is a trademark registered to Reproductive
Solutions for the commercial product they have developed that uses the patented technology.
Prien said sex selection coulddramatically increase the profitability of dairies and beef cattle feeder operations by producing a higher percentage of male or female animals as desired.
“Spending for flow cytometric sorting is estimated at $140 million per year,” Prien
said. “This low cost sexing will make sex selection available on a much wider scale
with a much larger market potential.”
-30-
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.
